Toward harmonized reporting of Alzheimer’s disease biomarkers in clinical practiceLuisa Agnelloon September 2, 2026 at 10:00 am
Clin Chem Lab Med. 2026 Sep 3. doi: 10.1515/cclm-2026-1113. Online ahead of print. ABSTRACT Cerebrospinal fluid biomarkers, and more recently blood-based biomarkers, are playing a pivotal role in reshaping the clinical management of neurodegenerative diseases, supporting early detection, biological diagnosis, patient stratification, prognostic assessment, therapeutic decision-making, and longitudinal disease monitoring. To effectively support clinical decision-making, … Read more